Dr. Luminița Gabriela Horga

Luminita Gabriela Horga has recently finished her PhD in Biotechnology at the Manchester Institute of Biotechnology in the UK.

Her thesis focuses on the engineering of bacteria using orthogonal riboswitches to reduce the costs associated with therapeutic protein production. During her PhD she was part of Campus Capital, the first European on-campus venture capital fund to evaluate business deals and increase brand awareness.She also worked in the pharmaceutical industry in cancer research during her placement year in Vienna at the Boehringer Ingelheim company. She obtained a Biotechnology with Business degree at the University of Manchester, UK.